Navigation Links
View Mex-3 Portable Xenon Headlight

ProductsView Mex-3 Portable Xenon Headlight
Company Kelleher Medical, Inc.
Item View Mex-3 Portable Xenon Headlight
Features Portable, lightweight, comfortable, cordless, rechargeable, nonfocusable, xenon illumination, inexpensive lamp replacement, uses "AA" alkaline or rechargeable batteries, optional optical loupes.
Description View Mex-3 is designed for out-patient surgery, hospital rounds and house calls.
Info Kelleher Medical, Inc.
Customer Service: (804) 323-4040
Web site: http://www.kellehermedical.com/

Related medicine products :

1. View Mex-3
2. Portable Mini Halogen Light
3. View Mex-2 Portable Xenon Headlight
4. Portable ABI Kit
5. Topcon Portable System
6. Suzanne Portable Recording System
7. CXDI-31 Portable DR System
8. CXDI-50G Portable DR System
9. Portable Operation Microscope
10. Compact Portable II A/B
11. i-STAT Portable Clinical Analyzer
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products:
(Date:11/21/2008)...Call/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL )...gly approved the proposals submitted to them relat...cals Industries Ltd. (Nasdaq: TEVA ). , , ...ort of the transaction by the Barr shareholders," ... are pleased with the progress that we continue to...
(Date:11/21/2008)...s cause remains a mysteryswept into Athens. The wa...oldiers and refugees of the war then raging betwee...s, social order broke down. Over the next three ye...third of its population. It lost the war too. The ...f the Golden Age of Greece. , The Plague of Ath...
(Date:11/21/2008)...-- A prestigious group of physicians, nurses, and ...sburg, VA on March 27-29, 2009 at the Williamsburg... cutting-edge therapeutic protocols, novel diagnos...hat impact patient care. The full program, faculty...vailable at www.bioconferences.com/wh , , ...
(Date:11/21/2008)...lent and smoking cessation less likely among perso...A.D.H.D.) In a study of smokers with attention de...ted elevated hyperactivity and impulsivity, with o...er 8 weeks than those with inattention symptoms al...tudy, now available online in Nicotine and Tobacc...
Breaking Medicine News(10 mins):Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2
...the primary protein linked to soy allergies in chi.../. The two lines already are adapted to Illinois-l...seeking to produce new varieties of allergy-free s...ineering. Crop scientists at the University of Il...
...e receptor for Helicobacter pylori as the decay-ac...lial cells in the stomach//. Blocking this intera... of peptic ulcer disease or gastric cancer. The re...ek’ in the May 12 issue of the Journal of Biologic...
...lans for slow suffocation of millions of poultry, ... According to Compassion in World Farming (CIWF) ...ulations 1995 have been amended under emergency pr...has been authorized for "ventilation shutdown" as ...
...ted that the centralization of hospital services i...ong distances// to receive health care. The limita...n made glaringly evident. Patients and their rel...em a significant issue especially because commerci...
Other Medicine News:Health News:Promise for Soya Allergy Sufferers 2Health News:Receptor for H.pylori Identified in Stomach 2
(Date:11/19/2008)...AND OAKS, Calif., Nov. 19 /PRNewswire-FirstCall/ -...eda Oncology Company, a subsidiary of,Takeda Phar...unced that,enrollment in the Phase 3 MONET1 trial...th paclitaxel and carboplatin for the first-line t...NSCLC) has been temporarily suspended,following a...
(Date:11/19/2008)...OCHELLE, N.Y., Nov. 19 Biotech sci...ogies to toxicology research to better understand ...of organ systems, reports Genetic Engineering &am...y interested in figuring out a new compound,s mech...tive toxicology technique, according to the Novemb...
(Date:11/18/2008)...N, November 19 NeuroDisc...rvice provider and drug development Company,and ...x: 4565), a leading,international biopharmaceutic... presenting further pivotal pre-clinical efficacy ... is a potential therapy for neuropathic pain and h...
(Date:11/18/2008)...OWNE, Va., Nov. 18 Fort...hered at a November national forum to consider cut...blic health and national economy from outbreaks of...unced today. , , Among those innovations: ,...y American kitchen table that detects highly conta...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Holiday Gifts for Those With Disabilities 26 Other Special Needs 4005 1Holiday Gifts for Those With Disabilities 26 Other Special Needs 4005 2Shopping Sprees Can Cost More Than You Think 3A How to Identify a Shopping Addiction 4002 1Shopping Sprees Can Cost More Than You Think 3A How to Identify a Shopping Addiction 4002 2Shopping Sprees Can Cost More Than You Think 3A How to Identify a Shopping Addiction 4002 3Study 3A HPV test beats Pap in detecting cervical cancer 4000 1Study 3A HPV test beats Pap in detecting cervical cancer 4000 2Study 3A HPV test beats Pap in detecting cervical cancer 4000 3OrbusNeichs Genous 28TM 29 Bio Engineered R Stent 28TM 29 is Subject of Sessions on Innovation at TCT 2007 559 1OrbusNeichs Genous 28TM 29 Bio Engineered R Stent 28TM 29 is Subject of Sessions on Innovation at TCT 2007 559 2
...ROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Jun 21, 2007... today announced that,detailed results from the Co...benign prostatic hyperplasia (BPH) will be present...beginning in September,at the South Central Americ...ngs. These independent podium presentations will b...
...CAGO, June 21, 2007 /PRNewswire/ -- , What and Whe... ACTOS(R),(pioglitazone HCl) will be presented in ...he American Diabetes Association in,Chicago: , , ...n high-risk type 2, diabetes patients treat... PROactive; Poster 0553-P presented on Saturda...
Other Medicine Technology:Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating,MacroVascular Outcomes Presented at the American Diabetes,Association 67th Scientific Sessions 2MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating,MacroVascular Outcomes Presented at the American Diabetes,Association 67th Scientific Sessions 3